Back20/20 Biolabs Common Stock Overview

20/20 Biolabs Common Stock Total Assets

Latest total assets for AIDX: $6.1M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$6.12M

Peer trimmed avg / median

Loading

20/20 Biolabs Common Stock Total Assets History

Loading

20/20 Biolabs Common Stock vs. peers: Total Assets Comparison

Loading

20/20 Biolabs Common Stock Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

20/20 Biolabs Common Stock (AIDX) FAQ

As of the most recent data (June 2026), AIDX shows a total assets of $6.1M. Scroll down for historical charts and peer comparison views.

Tracking AIDX's total assets over time shows whether 20/20 Biolabs Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has 20/20 Biolabs Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $6.1M) with ownership activity and broader fundamentals.